HUT43107A - Process for producing vaccine against melanome - Google Patents

Process for producing vaccine against melanome

Info

Publication number
HUT43107A
HUT43107A HU87472A HU47287A HUT43107A HU T43107 A HUT43107 A HU T43107A HU 87472 A HU87472 A HU 87472A HU 47287 A HU47287 A HU 47287A HU T43107 A HUT43107 A HU T43107A
Authority
HU
Hungary
Prior art keywords
melanome
vaccine against
producing vaccine
producing
vaccine
Prior art date
Application number
HU87472A
Other languages
Hungarian (hu)
Other versions
HU209144B (en
Inventor
Joseph P Brown
Karl E Hellstrom
Sridhar Pennathur
Charles D Estin
Shiu-Lok Hu
Gregory D Plowman
Anthony F Purchio
Timothy M Rose
Ingegerd Hellstrom
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT43107(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of HUT43107A publication Critical patent/HUT43107A/en
Publication of HU209144B publication Critical patent/HU209144B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HU87472A 1986-02-07 1987-02-06 Method for producing vaccina and active agent against melanome HU209144B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (2)

Publication Number Publication Date
HUT43107A true HUT43107A (en) 1987-09-28
HU209144B HU209144B (en) 1994-03-28

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
HU87472A HU209144B (en) 1986-02-07 1987-02-06 Method for producing vaccina and active agent against melanome

Country Status (18)

Country Link
JP (3) JP2664673B2 (en)
BE (1) BE1000175A3 (en)
CH (1) CH675424A5 (en)
DE (1) DE3703702C2 (en)
DK (1) DK63287A (en)
ES (2) ES2012815A6 (en)
FI (1) FI94836C (en)
GR (1) GR870195B (en)
HU (1) HU209144B (en)
IE (1) IE59597B1 (en)
IT (1) IT1222359B (en)
MX (1) MX9203574A (en)
NL (1) NL8700285A (en)
NO (1) NO178931C (en)
NZ (1) NZ219192A (en)
OA (1) OA08478A (en)
PT (1) PT84255B (en)
SE (2) SE506024C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (en) * 1998-05-15 1999-11-18 Roehnisch Tim Bacteriophage expression system for production of composition for induction of tumor specific responses
JP4414023B2 (en) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 Method and reagent for measuring arthritis-related melanotransferrin
JP4708027B2 (en) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Anti-cancer compositions and anti-infective disease compositions and methods of using them
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
SE506024C2 (en) 1997-11-03
BE1000175A3 (en) 1988-07-12
NO178931C (en) 1996-07-03
NZ219192A (en) 1991-10-25
FI870501A (en) 1987-08-08
JPH09135692A (en) 1997-05-27
SE8700466L (en) 1987-08-08
ES2017258A6 (en) 1991-01-16
HU209144B (en) 1994-03-28
MX9203574A (en) 1992-07-01
IE870319L (en) 1987-08-07
FI94836C (en) 1995-11-10
IT8719291A0 (en) 1987-02-06
IE59597B1 (en) 1994-03-09
GR870195B (en) 1987-06-10
DK63287A (en) 1987-08-08
JP2664673B2 (en) 1997-10-15
JPH08280390A (en) 1996-10-29
PT84255B (en) 1989-11-30
IT1222359B (en) 1990-09-05
DK63287D0 (en) 1987-02-06
NL8700285A (en) 1987-09-01
NO870475D0 (en) 1987-02-06
OA08478A (en) 1988-07-29
FI94836B (en) 1995-07-31
NO178931B (en) 1996-03-25
NO870475L (en) 1987-08-10
ES2012815A6 (en) 1990-04-16
JPS62294698A (en) 1987-12-22
FI870501A0 (en) 1987-02-06
DE3703702A1 (en) 1988-02-18
SE8700466D0 (en) 1987-02-06
DE3703702C2 (en) 1997-07-10
PT84255A (en) 1987-03-01
SE9202934D0 (en) 1992-10-07
CH675424A5 (en) 1990-09-28

Similar Documents

Publication Publication Date Title
EG18230A (en) Process for preparing 3-aryloxy-3-substituted propanamines
HUT43821A (en) Process for producing amlodipine-benzenesulfonate
YU34587A (en) Process for preparing purinic nucleozides
HUT48225A (en) Process for producing 2-chloro-5-chloromethylthiazole
EP0232182A3 (en) Process for producing bases
HUT47279A (en) Process for producing pyridazodiazepines
HUT46304A (en) Process for producing 3-pyrrolidinoles
EP0245960A3 (en) Process for preparing n-acyltetrahydroisoquinoline
HUT51635A (en) Process for producing glyphozate from n-phosphono-methyl-2-oxazolidone
HUT45241A (en) Process for producing naphthothiazepinone derivatives
HUT46029A (en) Process for producing inosose derivatives
HUT51327A (en) Process for producing coccidiosis vaccine
HUT47074A (en) Improved process for producing 1-amino-indane derivatives
HUT47294A (en) Process for producing pyridobenzoxadiazines
YU119887A (en) Process for preparing dihydroizoquinolines
EP0268820A3 (en) Process for producing 2-acylfuran derivatives
HUT44080A (en) Process for producing l-lysin
HUT43107A (en) Process for producing vaccine against melanome
HUT45073A (en) Process for producing substituted amino-alkanoyl-amino-alkyl-phosphonates
HUT47277A (en) Process for producing new pyrrolo-benzimidazols
HUT44008A (en) Process for producing n-sulfonylmethyl-formamides
PT86424A (en) Process for preparing substituted tetrahydropyridoindoles
YU213887A (en) Process for preparing new 1-aryloxi-3-amino-2-propanoles
HUT46035A (en) Process for producing 16-dehydro-20-oxopregnane derivatives
HUT45519A (en) Process for producing naphthothiazocinones

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee